NEWS CENTER

Beijing R&D Base: Nuokangda

Publish Time:

2025-02-28

Beijing Nuokanda Pharmaceutical Technology Co., Ltd. is an innovation-driven, full-chain pharmaceutical CRO enterprise specializing in formulation technology platforms tailored to clinical needs. It is recognized as a National High-Tech Enterprise, a National Intellectual Property Demonstration Enterprise, and hosts a Postdoctoral Research Station. For six consecutive years, the company has been ranked among the top 20 "China's Top 20 Pharmaceutical R&D Companies" by the All-China Federation of Industry and Commerce, and it has undertaken or participated in two key national major new drug development projects under the 13th Five-Year Plan. In 2023, Keyuan Pharmaceutical acquired a 12% stake in Nuokanda, making it the company's second-largest shareholder. Today, Nuokanda has become Keyuan Pharmaceutical's Beijing-based R&D hub.

Beijing Nuokangda Pharmaceutical Technology Co., Ltd. is an innovative, full-chain pharmaceutical CRO enterprise driven by clinical needs and built around a comprehensive formulation technology platform. It is recognized as a National Intellectual Property Demonstration Enterprise and hosts a postdoctoral workstation. For six consecutive years, the company has been ranked among the top companies on the "Top 20 Chinese Pharmaceutical R&D Companies" list, as selected by the All-China Federation of Industry and Commerce. Additionally, it has undertaken and participated in two key national major new drug development projects under the "13th Five-Year Plan."
In 2023, Keyuan Pharmaceutical acquired a 12% stake in Nuokanda, becoming the company's second-largest shareholder. Today, Nuokanda has evolved into Keyuan Pharmaceutical's Beijing R&D hub.

None